Brief Communicationposted 2023-07-26 17:22:43
Association of Antibiotic Exposure with Residual Cancer Burden and Pathologic Complete Response in Patients with HER2-negative stage II or III breast cancer Treated with Neoadjuvant Pembrolizumab in the ISPY-2 Trial
Amit Kulkarni, Aditya Jain, Patricia Jewett, Nidhi Desai, Laura Van 'T Veer, Gillian Hirst, Douglas Yee, and 1 more authors
Under Revision
at
Articleposted 2023-07-26 15:02:59
The deubiquitinating enzyme USP4 regulates BRCA1 stability and function
Genze Shao, Xueyuan Guo, Yanfang Ma, Runyu Liu, Ting Zhang, Qin Li, Fen Chang, and 4 more authors
Under Review
at
Articleposted 2023-07-07 13:39:41
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
Simona Pisegna, Simone Scagnoli, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo De Giorgi, and 25 more authors
Under Review
at
Articleposted 2023-06-26 17:26:49
TGFBR1*6A enhances breast cancer development through downregulation of p27
Kojo Agyemang, Allan Johansen, Grayson Barker, Michael Pennison, Hugo Jimenez, Kimberly Sheffield, Minghui Wang, and 4 more authors
Under Revision
at
Articleposted 2023-06-26 14:39:00
PARP-inhibitors Improve Progression-Free Survival in Breast Cancer Patients with Previous Platinum Exposure – A Systematic Review and Meta-Analysis
Beatriz Pessoa, Gabriela Brandao, Caroliny Da Silva, Emily Gatof, Siddhartha Yadav, Brenda Ernst, Lida Mina, and 5 more authors
Under Review
at
Articleposted 2023-06-09 19:00:45
Deep learning models predicting hormone receptor status in breast cancer trained on females do not generalize to males: further evidence of sex-based disparity in breast cancer
Subarnarekha Chatterji, Jan Niehues, Marko van Treeck, Chiara Loeffler, Oliver Saldanha, Gregory Veldhuizen, Didem Cifci, and 4 more authors
Under Review
at
Articleposted 2023-05-25 15:42:01
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
Stefan Wiemann, Lukas Beumers, Efstathios Vlachavas, Simone Borgoni, Luisa Schwarzmüller, Luca Penso-Dolfin, Birgitta Michels, and 8 more authors
Under Review
at
Articleposted 2023-05-19 21:03:58
Expression of the cGAS-STING pathway is associated with high levels of genomic instability and immune cell infiltration in breast cancer
Mengting Chen, Shibo Yu, Tineke van der Sluis, Mieke Zwager, Carolien Schröder, Bert Van der Vegt, Marcel van Vugt
Under Review
at
Articleposted 2023-05-10 05:35:54
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study
Laura Esserman, Tianyi Wang, Mandy Che, Yash Huilgol, Holly Keane, Deborah Goodman, Rashna Soonavala, and 4 more authors
Under Review
at
Articleposted 2023-05-05 09:43:00
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
Johan Staaf, Srinivas Veerla, Lennart Hohmann, Deborah Nacer, Johan Vallon-Christersson
Under Review
at